Lowe's Companies, Inc. (LOW): analysis and signal as of September 10, 2026
In short
The system assigns Lowe's a strong downward-oriented signal, with a three out of three vote and a score of -4,0 as of 10 September 2026. The main reason lies in the deteriorated technical momentum and the fiscal year 2026 guidance placed below consensus, which make the six-month risk/return profile asymmetric.
- Current signal
- strong (vote 3/3) divergence
- Deterministic score
- -4.0 → signal expected by the scale : no signal (September 10, 2026)
- Layers
- fundamentals : positive, price : negative, risks : negative, fundamentals : neutral, price : negative, risks : negative
Triggered rules
| Rule | Weight |
|---|---|
| penalizes a probable accounting manipulation profile (Beneish M-Score above the -1,78 threshold) | -3.0 |
| penalizes an asset whose net debt/EBITDA exceeds the threshold, and the use of leverage (margin/lombard) | -2.5 |
| favors a high and durable return on invested capital (ROIC), a marker of a lasting moat | +2.0 |
| penalizes direct holding of US securities in a CTO (US estate tax at death), favors a UCITS ETF domiciled in IE | -1.0 |
| favors high gross profitability (gross profit / assets), a robust predictor of returns | +1.0 |
| moderately penalizes an asset with very aggressive asset growth / investment (CMA factor favors conservatism), context-dependent | -0.5 |
Thesis
Lowe's retains sound operational quality, but three factors penalise the six-month risk/return profile: a deteriorated technical momentum, a steep US yield curve and a sector classification as consumer discretionary penalised by the macroeconomic regime. Fiscal year 2026 guidance sits below consensus and the compression of multiples reinforces this assessment. In the absence of an explicit invalidation of the bearish trend, the model maintains an unfavourable verdict on the stock.
Bull case
The FBM acquisition, valued at 8,8 billion dollars, must prove accretive to earnings per share from the first full year onwards. It accompanies the ramp-up of the Pro segment, while digital sales grow by 15,7 %. The dividend offers a growing yield of 2,55 % and factor quality displays a score of 3,4. Consensus targets remain well above the current price, but the model does not grant them the status of dominant scenario.
Bear case
Fiscal year 2026 earnings per share guidance stands at 12,25 dollars, below a consensus of 12,88 dollars. DIY comparable sales up 0,2 % look anaemic in an expansionary macroeconomic regime. Six-month performance deteriorates, with an intraday and overnight signature of -29,3 %, characteristic of fragile retail investor flows, and the price trades 16 % below its 200-session moving average. The sector additionally faces steep long-term rates, with the US two-ten year curve having steepened by 0,40 point, and the company remains exposed to tariffs on imported goods.
Scenarios
The bullish scenario, with a probability below 25 %, rests on the FBM catalyst and a sector rebound in housing. The central scenario, with a probability below 55 %, describes a sideways consolidation of the stock. The bearish scenario, with a probability below 20 %, assumes a further downward revision of guidance and a pullback in long-term rates.
Risks
The identified risks combine direct tariff exposure on imported goods, sensitivity to US long-term rates and the housing cycle, as well as a high level of debt weighing on the deterministic score. An unfavourable Beneish M-Score introduces uncertainty about accounting quality and a class action investigation opened on 15 July 2026 adds a legal dispute. Finally, the materialisation of the expected FBM accretion depends on proper execution of the integration.
Market positioning (short sellers)
- Short interest / shares outstanding
- 1.64 %
- Days to cover
- 4.01
- Settlement date
- 2026-08-14
- Source
- FINRA (disseminated on 2026-08-26)
Signal history (last 12 months)
| Date | Signal | New fact |
|---|---|---|
| strong (3/3) | No change. The deterministic score remains stable at -4,0 and no new fact dated between 6 and 10 September 2026 justifies a modification. The publication of second quarter fiscal year 2026 results, dated 19 August 2026, the downward revision of a price target by an analyst on 27 August 2026 and the class action investigation opened on 15 July 2026 predate the verdict of 6 September 2026. | |
| strong (2/3) | No change. The analysis remains personal and does not constitute advice. | |
| strong (2/3) | No change. The previous negative verdict is confirmed by the convergence of the three layers of analysis and no new quantified element after 3 September 2026 justifies a revision of the signal or of the associated action. The deteriorated intraday decomposition and the confirmation of comparable sales at plus 0,2 % in the second quarter reinforce the negative reading. The analysis remains personal and does not constitute advice. |
Frequently asked questions
What is the verdict delivered on Lowe's as of 10 September 2026?
The verdict is negative with a high level of confidence: the signal is strong, the vote is unanimous at three out of three and the score stands at -4,0. The model judges the six-month risk/return profile asymmetric, due to the deteriorated technical momentum, the steep yield curve and a penalised sector classification as consumer discretionary.
Why does the fiscal year 2026 guidance weigh on the verdict?
Management announces earnings per share of 12,25 dollars for fiscal year 2026, below the consensus of 12,88 dollars. This gap feeds the compression of multiples and the asymmetry of the risk/return profile. DIY comparable sales up 0,2 % in the latest quarter also look weak against an expansionary macroeconomic regime, which reinforces the negative reading.
What does the FBM acquisition represent for the bullish thesis?
This 8,8 billion dollars acquisition must be accretive to earnings per share from the first full year onwards. It supports the ramp-up of the Pro segment, while digital sales grow by 15,7 %. The dividend shows a growing yield of 2,55 % and the factor quality score reaches 3,4.
What main risks surround the stock?
The main risks combine direct tariff exposure on imported goods, sensitivity to long-term rates illustrated by a two-ten year curve steepened by 0,40 point, a high level of debt and an unfavourable Beneish M-Score. A class action investigation opened on 15 July 2026 adds a legal risk. The deteriorated six-month performance, with an intraday and overnight signature of -29,3 %, reflects fragile retail investor flows.
Has a new fact modified the analysis since the previous verdict?
No new fact dated between 6 and 10 September 2026 justifies a revision. The publication of second quarter fiscal year 2026 results, dated 19 August 2026, the downward revision of a price target by an analyst on 27 August 2026 and the class action investigation opened on 15 July 2026 all predate the verdict of 6 September 2026. The deterministic score remains stable at -4,0.
Sources
The official filings below are the issuer's own, matched to this stock by its identifier (LEI, CIK or ISIN). The figures quoted above come from an automated arbitration: they have not been re-checked one by one.
- — 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers (SEC · 8-K)
- — 10-Q (SEC · 10-Q)
- — 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits (SEC · 8-K)
- — 5.07 Submission of Matters to a Vote of Security Holders (SEC · 8-K)
- — 10-Q (SEC · 10-Q)
Automated AI analysis: limitations and transparency
- This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
- Tool and analysis: QDNA, Aurélien Ambert.
- Analysis (arbitration) completed on September 10, 2026; this page was completed on September 11, 2026 at 00:30 (UTC).
- Interests: no position in the stock analysed (LOW) is recorded in the data consulted on (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
- This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
- Methodology: analysis chain, score formula and scale described on the public methodology page.
- Analysis horizon: 2035.
See also
- Neighbouring stock in the same sector: CVS Health Corporation (CVS)
- All analysed stocks
- Public methodology